Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.
2.

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

Zarate CA Jr, Payne JL, Singh J, Quiroz JA, Luckenbaugh DA, Denicoff KD, Charney DS, Manji HK.

Biol Psychiatry. 2004 Jul 1;56(1):54-60.

PMID:
15219473
3.

Pramipexole: augmentation in the treatment of depressive symptoms.

Gupta S, Vincent JL, Frank B.

CNS Spectr. 2006 Mar;11(3):172-5.

PMID:
16575373
4.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

J Clin Psychiatry. 2009 Feb;70(2):223-31. Epub 2008 Dec 30.

PMID:
19200421
5.

A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.

Cusin C, Iovieno N, Iosifescu DV, Nierenberg AA, Fava M, Rush AJ, Perlis RH.

J Clin Psychiatry. 2013 Jul;74(7):e636-41. doi: 10.4088/JCP.12m08093.

PMID:
23945458
6.

Pramipexole in treatment-resistant depression: a 16-week naturalistic study.

Lattanzi L, Dell'Osso L, Cassano P, Pini S, Rucci P, Houck PR, Gemignani A, Battistini G, Bassi A, Abelli M, Cassano GB.

Bipolar Disord. 2002 Oct;4(5):307-14.

PMID:
12479663
7.

Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series.

Perugi G, Toni C, Ruffolo G, Frare F, Akiskal H.

Pharmacopsychiatry. 2001 Jul;34(4):137-41.

PMID:
11518474
8.

The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.

Zhang ZJ, Kang WH, Li Q, Tan QR.

J Psychiatr Res. 2007 Nov;41(10):828-36. Epub 2006 Sep 29.

PMID:
17010995
9.

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD.

J Clin Psychiatry. 1999 Feb;60(2):79-88.

PMID:
10084633
10.

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study.

McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH.

Bipolar Disord. 2002 Jun;4(3):207-13.

PMID:
12180276
11.

Comparison of pramipexole, fluoxetine, and placebo in patients with major depression.

Corrigan MH, Denahan AQ, Wright CE, Ragual RJ, Evans DL.

Depress Anxiety. 2000;11(2):58-65.

PMID:
10812530
12.

Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.

Sachs GS, Ice KS, Chappell PB, Schwartz JH, Gurtovaya O, Vanderburg DG, Kasuba B.

J Clin Psychiatry. 2011 Oct;72(10):1413-22. doi: 10.4088/JCP.09m05934.

PMID:
21672493
14.

Pramipexole in treatment-resistant depression: an extended follow-up.

Cassano P, Lattanzi L, Soldani F, Navari S, Battistini G, Gemignani A, Cassano GB.

Depress Anxiety. 2004;20(3):131-8.

PMID:
15549689
15.

Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.

McIntyre RS, Cucchiaro J, Pikalov A, Kroger H, Loebel A.

J Clin Psychiatry. 2015 Apr;76(4):398-405. doi: 10.4088/JCP.14m09410.

17.

Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.

Calabrese JR, Ketter TA, Youakim JM, Tiller JM, Yang R, Frye MA.

J Clin Psychiatry. 2010 Oct;71(10):1363-70. doi: 10.4088/JCP.09m05900gry. Epub 2010 Jul 27.

PMID:
20673554
18.

Divalproex in the treatment of bipolar depression: a placebo-controlled study.

Davis LL, Bartolucci A, Petty F.

J Affect Disord. 2005 Apr;85(3):259-66.

PMID:
15780695
19.

Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.

Sporn J, Ghaemi SN, Sambur MR, Rankin MA, Recht J, Sachs GS, Rosenbaum JF, Fava M.

Ann Clin Psychiatry. 2000 Sep;12(3):137-40.

PMID:
10984002
20.

A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.

Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.

J Clin Psychiatry. 2011 Oct;72(10):1405-12. doi: 10.4088/JCP.09m05355gre.

PMID:
21367355

Supplemental Content

Support Center